Negative impact of reduced exocrine pancreatic function on sarcopenia risk in the asymptomatic general population (opens in new tab)

BackgroundIn patients with pancreatic disease, exocrine insufficiency facilitates sarcopenia. Here, we investigated whether impaired exocrine function in the asymptomatic general population is also associated with sarcopenia.MethodsWe pooled data from two independent cohorts of 5,598 participants without history of pancreatic disease enrolled in the Study of Health in Pomerania. The association between impaired exocrine pancreatic function (fecal elastase ≤ 200 μg/g) and sarcopenia was determ...